aluminum sulfate has been researched along with Whooping Cough in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Caution, K; Deora, R; Dubey, P; Fullen, AR; Guo, M; Hall, JM; Huang, Y; Marion, K; Maynard, JA; Quataert, SA; Shamseldin, MM; Yount, KS | 1 |
| Casella, CR; Mitchell, TC | 1 |
| D'Agostino, R; Deora, R; Dubey, P; Ganguly, T; Jennings-Gee, J; Quataert, S | 1 |
| Allen, AC; Higgins, S; Lavelle, EC; McLoughlin, RM; Mills, KH; Misiak, A; Ross, PJ; Sutton, CE; Walsh, K | 1 |
| BELL, JA | 1 |
| BRADFORD, WL; DAY, E; MARTIN, F | 1 |
| HOUSTON, BJ; PASCHKIS, MM; TYSON, RM | 1 |
1 review(s) available for aluminum sulfate and Whooping Cough
| Article | Year |
|---|---|
No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.
Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Viral; Diphtheria-Tetanus-acellular Pertussis Vaccines; Drug-Related Side Effects and Adverse Reactions; Humans; Lipid A; Pain; Papillomavirus Infections; Papillomavirus Vaccines; Toll-Like Receptor 4; Treatment Outcome; Vaccination; Whooping Cough | 2017 |
6 other study(ies) available for aluminum sulfate and Whooping Cough
| Article | Year |
|---|---|
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Animals; Bordetella pertussis; CD4-Positive T-Lymphocytes; Female; Interleukin-17; Male; Mice; Pertussis Vaccine; Whooping Cough | 2023 |
The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.
Topics: Adaptive Immunity; Adjuvants, Immunologic; Alum Compounds; Animals; Bordetella pertussis; Down-Regulation; Immunity, Innate; Lung; Mice; Pertussis Vaccine; Vitamin B 12; Whooping Cough | 2018 |
Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
Topics: Adaptive Immunity; Alum Compounds; Animals; Bordetella pertussis; Immunity, Cellular; Interleukin-17; Interleukin-1beta; Interleukin-4; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Pertussis Vaccine; Th1 Cells; Th17 Cells; Vaccination; Whooping Cough | 2013 |
Pertussis immunization; use of two doses of an alum-precipitated mixture of diphtheria toxoid and pertussis vaccine.
Topics: Alum Compounds; Diphtheria Toxoid; Humans; Immunity; Pertussis Vaccine; Vaccination; Whooping Cough | 1948 |
Humoral antibody formation in infants aged 1 to 3 months injected with a triple (diphtheria-tetanus-pertussis) alum-precipitated antigen.
Topics: Alum Compounds; Antibodies; Antibody Formation; Antigens; Diphtheria; Diphtheria-Tetanus-acellular Pertussis Vaccines; Diphtheria-Tetanus-Pertussis Vaccine; Humans; Infant; Tetanus; Whooping Cough | 1949 |
Measure of immunologic responses to an improved preparation of diphtheria and tetanus toxoids (alum precipitated) combined with pertussis vaccine.
Topics: Alum Compounds; Diphtheria; Humans; Pertussis Vaccine; Tetanus; Tetanus Toxoid; Whooping Cough | 1950 |